Type II diabetic nephropathy: Its clinical course and therapeutic implications

Seminars in Nephrology

Volumn 17, Issue 2, 1997, Pages 132-147

  Rodby, Roger A ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; BLOOD PRESSURE REGULATION; CIGARETTE SMOKING; DIABETES CONTROL; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA POLYMORPHISM; HYPERGLYCEMIA; HYPERTENSION; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN RESTRICTION; PROTEINURIA; RISK FACTOR;

EID: 0030958164     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Diabetes in America, 2nd ed. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468, 1995
2. Senator H: Die Erkrankungen der Nieren. Wien, Austria, bei Alfred Holder, 1896, pp 138-139, 246-247
3. Kimmeisteil P, Wilson C: Intercapillary lesions in the glomeruli of kidney. Am J Pathol 12:83-97, 1936
4. Fahre J, Balant LP, Dayer PG, et al: The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Int 21:730-738, 1982
5. Krolewski AS, Warram JH, Christlieb AR, et al: The changing natural history of nephropathy in type I diabetes. Am J Med 7:786-794, 1985
6. Nelson RG: The natural history of renal disease in noninsulin-dependent diabetes mellitus: Lessons from the Pima Indians, in Grünfeld JP, Bach JF, Kreis H, Maxwell MH (eds): Advances in Nephrology, vol 24. St. Louis, MO, Mosby, 1995, pp 145-156
7. Raine AE: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 36:99-104, 1993
8. Michaelis D, Jutzi E: Epidemiologie des diabetes mellitus in der bevölkerung der ehemaliigen DDR. Altersund geschlechtsspezifische inzidenz-und prävalenztrenz im zeitraum 1960-1987. Z Klin Med 46:59-63, 1991
9. Harris CL, Hewett-Emmett D, Bertin TK, et al: Origens of U.S. Hispanics: Implications for diabetes. Diabetes Care 14:649-654, 1991 (Suppl 3)
10. Cowie CC, Port FK, Wolfe RA, et al: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321:1074-1079, 1989
11. Freedman BI, Ober KP, Tuttle AB, et al: Familial clustering of end-stage renal disease (ESRD) in African Americans (AA) with non-insulin-dependent diabetes mellitus (NIDDM). J Am Soc Nephrol 5:377, 1994 (abstr)
12. Pettitt DJ, Saad MF, Bennett PH, et al: Familial predisposition to renal disease in two generations of Pima Indians with type II (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
13. Schmidt K, Pesce C, Liu Q, et al: Large glomerular size in Pima Indians: Lack of change with diabetic nephropathy. J Am Soc Nephrol 3:229-235, 1992
14. Ohno T, Kato N, Shimizu M, et al: Effect of age on the development or progression of albuminuria in non-insulindependent diabetes mellitus (NIDDM) without hypertension. Diabetes Res 22:115-121, 1993
15. Keller CK, Bergis FH, Fliser D, et al: How frequent is microalbuminuria (MA) in type II diabetes of recent onset and is MA related to genetic factors. J Am Soc Nephrol 5:378, 1994 (abstr)
16. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 295:515-517, 1987
17. Barzilay J, Warram JH, Bak M, et al: Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 41:723-730, 1992
18. Mangali R, Bending JJ, Scott G, et al: Increased sodium-lithium counter-transport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318:146-150, 1988
19. Fujita J, Tsuda K, Seno M, et al: Erythrocyte sodiumlithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM. Diabetes Care 17:977-982, 1994
20. Hasslacher C, Wolfrum M, Stech G, et al: Diabetische nephropathie bei typ-II-diabetes. Dtsch Med Wochenschr 112:1445-1449, 1987
21. Nelson RG, Pettitt DJ, Baird HR, et al: Pre-diabetic blood pressure predicts urinary albumin secretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 36:998-1001, 1993
22. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
23. U.K. Prospective Diabetes Study Group: UKPDS. VIII. Study design, progress, and performance. Diabetologia 34:877-890, 1991
24. Savage S, Johnson Nagel N, Estacio RO, et al: Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 25:836-844, 1995
25. Goldschmid MG, Domin WS, Ziemer DC, et al: Diabetes in urban African-Americans II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes. Diabetes Care 18:995-961, 1995
26. Dasmahapatra A, Bale A, Raghuwanshi MP, et al: Incipient and overt diabetic nephropathy in African Americans with NIDDM. Diabetes Care. 17:297-304, 1994
27. Lee ET, Lee VS, Lu M, et al: Incidence of renal failure in NIDDM, The Oklahoma Indian diabetes study. Diabetes 43:572-579, 1994
28. Nelson RG, Knowler WC, Pettitt, et al: Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 18:182-187, 1995
29. Olivarius NF, Andreasen AH, Keiding N, et al: Epidemiology of renal involvement in newly-diagnosed middleaged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice," Denmark. Diabetologia 36:1007-1016, 1993
30. Yoshida H, Kon V, Ichikawa I: Polymorphisms of the renin-angiotensin system genes in progressive renal diseases. Kidney Int 50:732-744, 1996
31. Yoshida H, Mitarai T, Kawamura T, et al: Role of the deletion polymorphism of the angiotensin converting enzyme gene on the progression and therapeutic responsiveness of IgA nephropathy. 5 Clin Invest 96:2162-2169, 1995
32. Schmidt S, Schöne N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47:1176-1181, 1995
33. Dudley CRK, Keavney B, Stratton IM, et al: U.K. prospective diabetes study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1911, 1995
34. Yoshida H, Kuriyama S, Atsumi Y, et al: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657-664, 1996
35. Mogensen CE, Schmilz A, Christensen CK: Comparitive renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes/Metabolism Rev 4:453-483, 1988
36. Tuttle KR, Stein JH, De Fronzo R: The natural history of diabetic nephropathy. Semin Nephrol 10:184-193, 1990
37. Wiseman MJ, Saunders AJ, Keen H, et al: Effect of strict glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312:617-621, 1985
38. Schmilz A, Gundersen HJG, Østerby R: Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Diabetes 37:38-43, 1988
39. Østerby R, Gall M-A, Schmilz A, et al: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064-1070,-1993
40. Fraser IR, Nicholls KM, Kincaid-Smith PS: Glomerular volume in non-insulin dependent diabetes mellitus. J Am Soc Nephrol 2:289, 1991 (abstr)
41. Nowack R, Raum E, Blum W, et al: Renal heodynamics in recent-onset type II diabetes. Am J Kidney Dis 20:342-347, 1992
42. Myers BD, Nelson RG, Williams GW, et al: Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 88:524-530, 1991
43. Østerby R: Early phases in the development of diabetic glomerulosclerosis. Acta Med Scand 574:1-80, 1975 (Suppl)
44. Hayashi H, Karasawa R, Inn H, et al: An electron microscopic study of glomeruli in Japanese patients with noninsulin dependent diabetes mellitus. Kidney Int 41:749-757, 1992
45. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 313:673-689, 1987
46. Alzaid AA: Microalbuminuria in patients with NIDDM: An overview. Diabetes Care 19:79-89, 1996
47. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
48. Viberti GC, Hill RC, Jarrett RJ, et al: Microalbuminmuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432, 1982
49. Feldt-Rasmussen B, Borch-Johnson K, Decken T, et al: Microalbuminuria: An important diagnostic tool. J Diabetes Complications 8:137-145, 1994
50. Mykkänen L, Haffner SM, Kuusisto J, et al: Microalbuminuria precedes the development of NIDDM. Diabetes 43:552-557, 1994
51. Haffner SM, Gonzáles C, Valdez RA, et al: Is microalbuminuria part of the prediabetic state? The Mexico City diabetes study. Diabetologia 32:1002-1006, 1993
52. Decken T, Feldt-Rasmussen B, Borch-Johnsen K, et al: Albuminuria reflects widespread vascular damage: The Steno hypothesis. Diabetologia 32:219-226, 1989
53. Pugh JA, Medina R, Ramirez M: Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 36:1094-1098, 1993
54. Humphrey LL, Ballard DJ, Frohnert PP, et al: Chronic renal failure in non-insulin-dependent diabetes mellitus. A population based study in Rochester, Minnesota. Ann Intern Med 111:788-796, 1989
55. Hasslacher C, Bostedt-Kiesel A, Kempe HP, et al: Effect of metabolic factors and blood pressure on kidney function in proteinuria type 2 (non-insulin dependent) diabetic patients. Diabetologia 36:1051-1056, 1993
56. Gall MA, Nielsen FS, Smidt UM, et al: The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 36:1071-1078, 1993
57. Myers BD, Nelson RG, Tan M, et al: Progression of overt nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 47:1781-1789, 1995
58. Bruce R, Williams L, Cundy T: Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus. Aust NZ J Med 24:390-395, 1994
59. Ordonez JD, Hiatt RA: Comparison of type II and type I diabetics treated for end-stage renal disease in a large propaid health plan population. Nephron 51:524-529, 1989
60. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 9:1097-1102, 1994
61. Nelson RG, Sievers ML, Knowler WC, et al: Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81:987-995, 1990
62. Parving HH, Gall MA, Skøtt P, et al: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758-762, 1992
63. Schwanz MM, Lewis EJ, Leonard-Martin TC, et al: Renal clinicopathology of type II diabetes mellitus (DM). J Am Soc Nephrol 7:1364, 1996
64. Lipkin GW, Yeates C, Howie A, et al: More than one third of type 2 diabetics with renal disease do not have diabetic nephropathy: A prospective study. J Am Soc Nephrol 5:379, 1994 (abstr)
65. Gambara V, Mecca G, Remuzzi G, et al: Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 3:1458-1466, 1993
66. Zatz R, Dunn BR, Meyer TW, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
67. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long-term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
68. Noth RH, Krolewski AS, Kaysen GA, et al: Diabetic nephropathy: hemodynamic basis and implications for disease management. Ann Intern Med 110:795-813, 1989
69. Vora JP, Zimsen SM, Houghton DC, et al: Evolution and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J Am Soc Nephrol 7:113-117, 1996
70. Gabbay KH: Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Ann Rev Med 26:521-536, 1975
71. Cerami A, Stevens VJ, Monnier VM: Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus. Metabolism 28:431-437, 1979
72. Brownlee M, Cerami A: The biochemistry of the complications of diabetes mellitus. Ann Rev Biochem 50:385-432, 1981
73. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
74. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537, 1984
75. Makita Z, Radoff S, Rayfield EJ, et al: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
76. Vlassara H: Advanced nonenzymatic tissue glycosylation: Cell-mediated interactions implicated in the complications associated with diabetes and aging. Blood Purif 8:223-232, 1990
77. Lee TS, MacGregor LC, Fluharty SJ, King GL: Differential regulation of protein kinase C and (Na, K)-adenosine triphosphatase activity by elevated glucose levels in retinal capillary endothelial cells. J Clin Invest 83:90-94, 1989
78. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: A randomized prospective 6year study. Diabetes Res Clin Pract 28:103-117, 1995
79. Parving HH, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive therapy reduces rate of decline in kidney function in diabetic nephropathy. Lancet 32:1175-1179, 1983
80. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD for the Collaborative Study Group: The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
81. Kasiske BL, Kalil RSN, Ma JZ, et al: Effect of antihypertensive therapy in patients with diabetes. A meta-regression analysis. Ann Intern Med 118:129-138, 1993
82. Viberti G, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275-279, 1994
83. Mathiesen ER, Hommel E, Giese J, Parving HH: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 303:81-87, 1991
84. Ravid M, Savin H, Jutrin I, et al: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
85. Lebovitz H, Cnaan A, Wiegmann T, et al: Enalapril slows the progression of renal disease in non-insulin dependent diabetes mellitus (NIDDM): Results of a 3-year multicenter randomized, prospective, double-blinded study. J Am Soc Nephrol 3:335, 1992 (abstr)
86. Lebovitz HE, Wiegman TB, Cnaan A, et al: Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 45:5150-5155, 1994
87. Nielsen FS, Rossing P, GAII MA, et al: Impact of lisinopril and stenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 43:1108-1113, 1994
88. Bakris GL: The effects of calcium antagonists on renal hemodynamics, urinary protein excretion, and glomerular morphology in diabetic states. J Am Soc Nephrol 2:S21-S29, 1991
89. Demarie BK, Bakris GL: Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 113:987-988, 1990
90. Bakris GL: Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 112:707-708, 1990
91. Klahr S, Levey AS, Beck GJ, et al, for the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
92. Zeller K, Whittaker E, Sullivan L, et al: Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324:78-84, 1991